Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors.
Cancer Chemother Pharmacol. 2011 Oct;68(4):959-70. doi: 10.1007/s00280-011-1565-4. Epub 2011 Feb 9.
Cancer Chemother Pharmacol. 2011.
PMID: 21305290
Clinical Trial.
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors.
Traynor AM, Gordon MS, Alberti D, Mendelson DS, Munsey MS, Wilding G, Gammans RE, Read WL.
Traynor AM, et al. Among authors: munsey ms.
Invest New Drugs. 2010 Aug;28(4):509-15. doi: 10.1007/s10637-009-9264-2. Epub 2009 May 13.
Invest New Drugs. 2010.
PMID: 19434370
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.